104 related articles for article (PubMed ID: 11189505)
21. Thyroid dysfunction after bone marrow transplantation for primary immunodeficiency without the use of total body irradiation in conditioning.
Slatter MA; Gennery AR; Cheetham TD; Bhattacharya A; Crooks BN; Flood TJ; Cant AJ; Abinun M
Bone Marrow Transplant; 2004 May; 33(9):949-53. PubMed ID: 15004542
[TBL] [Abstract][Full Text] [Related]
22. Treatment of relapsed acute lymphoblastic leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a prospective study.
Choi SJ; Lee JH; Lee JH; Kim S; Lee YS; Seol M; Ryu SG; Lee JS; Kim WK; Jang S; Park CJ; Chi HS; Lee KH
Bone Marrow Transplant; 2005 Jul; 36(2):163-9. PubMed ID: 15937507
[TBL] [Abstract][Full Text] [Related]
23. [Hematopoietic stem cell transplantation with busulfanthiotepa-cyclophosphamide conditioning for pediatric patients with high-risk acute lymphoblastic leukemia].
Umeda K; Lin YW; Watanabe K; Adachi S; Usami I; Akiyama Y; Kubota M; Nakahata T
Rinsho Ketsueki; 2001 Sep; 42(9):685-90. PubMed ID: 11680979
[TBL] [Abstract][Full Text] [Related]
24. Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphoma.
Costa LJ; Micallef IN; Inwards DJ; Johnston PB; Porrata LF; Litzow MR; Ansell SM
Br J Haematol; 2008 Oct; 143(2):268-73. PubMed ID: 18699848
[TBL] [Abstract][Full Text] [Related]
25. Long-term results of allogeneic bone marrow transplantation for 108 adult patients with acute lymphoblastic leukemia: favorable outcome with BMT at first remission and HLA-matched unrelated donor.
Chim CS; Lie AK; Liang R; Au WY; Kwong YL
Bone Marrow Transplant; 2007 Aug; 40(4):339-47. PubMed ID: 17572712
[TBL] [Abstract][Full Text] [Related]
26. A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phase.
Elmaagacli AH; Runkel K; Steckel N; Opalka B; Trenschel R; Seeber S; Schaefer UW; Beelen DW
Bone Marrow Transplant; 2001 Apr; 27(8):809-15. PubMed ID: 11477437
[TBL] [Abstract][Full Text] [Related]
27. Single-centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukaemia in childhood: similar survival after matched-related and matched-unrelated donor transplants.
Al-Kasim FA; Thornley I; Rolland M; Lau W; Tsang R; Freedman MH; Saunders EF; Calderwood S; Doyle JJ
Br J Haematol; 2002 Feb; 116(2):483-90. PubMed ID: 11841456
[TBL] [Abstract][Full Text] [Related]
28. Fludarabine, cytarabine, and mitoxantrone (FLAM) for the treatment of relapsed and refractory adult acute lymphoblastic leukemia. A phase study by the Polish Adult Leukemia Group (PALG).
Giebel S; Krawczyk-Kulis M; Adamczyk-Cioch M; Jakubas B; Palynyczko G; Lewandowski K; Dmoszynska A; Skotnicki A; Nowak K; Holowiecki J;
Ann Hematol; 2006 Oct; 85(10):717-22. PubMed ID: 16832677
[TBL] [Abstract][Full Text] [Related]
29. Growth and endocrine function in children with acute myeloid leukaemia after bone marrow transplantation using busulfan/cyclophosphamide.
Afify Z; Shaw PJ; Clavano-Harding A; Cowell CT
Bone Marrow Transplant; 2000 May; 25(10):1087-92. PubMed ID: 10828870
[TBL] [Abstract][Full Text] [Related]
30. Intravenous busulfan and melphalan, tacrolimus, and short-course methotrexate followed by unmodified HLA-matched related or unrelated hematopoietic stem cell transplantation for the treatment of advanced hematologic malignancies.
Small TN; Young JW; Castro-Malaspina H; Prockop S; Wilton A; Heller G; Boulad F; Chiu M; Hsu K; Jakubowski A; Kernan NA; Perales MA; O'Reilly RJ; Papadopoulos EB
Biol Blood Marrow Transplant; 2007 Feb; 13(2):235-44. PubMed ID: 17241929
[TBL] [Abstract][Full Text] [Related]
31. Late thyroid toxicity in 153 long-term survivors of allogeneic bone marrow transplantation for acute lymphoblastic leukaemia.
Berger C; Le-Gallo B; Donadieu J; Richard O; Devergie A; Galambrun C; Bordigoni P; Vilmer E; Plouvier E; Perel Y; Michel G; Stephan JL
Bone Marrow Transplant; 2005 May; 35(10):991-5. PubMed ID: 15806126
[TBL] [Abstract][Full Text] [Related]
32. [Unrelated donor allogenetic marrow transplantation in treatment of acute and chronic leukemia].
Huang H; Lin M; Meng H
Zhonghua Yi Xue Za Zhi; 2001 Mar; 81(5):263-7. PubMed ID: 11798883
[TBL] [Abstract][Full Text] [Related]
33. Bone marrow transplantation in children with severe aplastic anemia using a conditioning regimen containing 3 Gy of total body irradiation, cyclophosphamide with or without antithymocyte globulin.
Inagaki J; Nagatoshi Y; Kawano Y; Saito Y; Takahashi D; Nagayama J; Shinkoda Y; Hirata H; Okamura J
Pediatr Transplant; 2007 Mar; 11(2):180-6. PubMed ID: 17300498
[TBL] [Abstract][Full Text] [Related]
34. Bone marrow transplantation nephropathy after an intensified conditioning regimen with radioimmunotherapy and allogeneic stem cell transplantation.
Zenz T; Schlenk RF; Glatting G; Neumaier B; Blumstein N; Buchmann I; von Harsdorf S; Ringhoffer M; Wiesneth M; Keller F; Kotzerke J; Röttinger E; Stilgenbauer S; Döhner H; Reske SN; Bunjes D
J Nucl Med; 2006 Feb; 47(2):278-86. PubMed ID: 16455634
[TBL] [Abstract][Full Text] [Related]
35. Disease- or therapy-related bone marrow damage cannot be overcome by changes in stem cell source or dose in allogeneic transplantation.
Novotny JR; Rosenthal C; Elmaagacli AH; Dürig J; Beelen DW; Dührsen U
Eur J Haematol; 2004 Jul; 73(1):1-9. PubMed ID: 15182331
[TBL] [Abstract][Full Text] [Related]
36. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Ringdén O; Labopin M; Gorin NC; Le Blanc K; Rocha V; Gluckman E; Reiffers J; Arcese W; Vossen JM; Jouet JP; Cordonnier C; Frassoni F
J Clin Oncol; 2004 Feb; 22(3):416-23. PubMed ID: 14691124
[TBL] [Abstract][Full Text] [Related]
37. Bone marrow transplantation from unrelated donors for patients with adult T-cell leukaemia/lymphoma.
Nakase K; Hara M; Kozuka T; Tanimoto K; Nawa Y
Bone Marrow Transplant; 2006 Jan; 37(1):41-4. PubMed ID: 16247419
[TBL] [Abstract][Full Text] [Related]
38. [A second allogeneic transplantation with a mild conditioning regimen in a patient with a posttransplantation relapse of lymphoblastic lymphoma after achieving aplasia with Daunoxome and alkeran].
Obukhova EE; Melkova KN; Tugova SV; Konchalovskiĭ MV; Baranov AE
Ter Arkh; 2000; 72(7):68-9. PubMed ID: 10983327
[No Abstract] [Full Text] [Related]
39. Bone marrow transplantation for advanced acute lymphoblastic leukemia in young people: a comparison of two conditioning regimens.
Graham-Pole J; Elfenbein G; Gross S; Higby D; Marcus R; O'Leary M; Weiner R
Bone Marrow Transplant; 1987 Jun; 2(1):85-9. PubMed ID: 3332160
[No Abstract] [Full Text] [Related]
40. Constrictive pericarditis post allogeneic bone marrow transplant for Philadelphia-positive acute lymphoblastic leukaemia.
Cavet J; Lennard A; Gascoigne A; Finney RD; Lucraft HH; Richardson C; Taylor PR; Proctor SJ; Jackson GH
Bone Marrow Transplant; 2000 Mar; 25(5):571-3. PubMed ID: 10713638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]